For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Tyson Foods: Coronavirus (COVID-19) Company Impact
Tyson Foods: Coronavirus (COVID-19) Company Impact reports key findings as of May 29, 2020 based on market analysis and brand diversification by industry and geography.
Tyson has been experiencing a significantly difficult time in its operations due to the COVID-19 outbreak in the US. Its food retail sales, predominantly meat , will inevitably see some losses. However, its key market, the US, is likely to display some resilience, which could help the company to recover from the crisis quicker than other global players in the industry.
- Tyson Foods' concentration on meat products in the US will give it some resilience against the pandemic.
- Lack of diversification and over-reliance on meat sector in Tyson's food business means that it should focus heavily on defensive strategies in its core areas.
- Although Tyson has been experiencing a difficult time due to COVID-19, its meat business may have some resilience due to its heavy focus on the US.
Reasons to Buy
- Understand the challenges and opportunities for a specific company in order to tap into what is really impacting the industry.
- Gain a broader appreciation of the fast-moving consumer goods industry by gaining insights from both within and outside of your sector.
- Access valuable strategic take-outs to help direct future decision-making and inform new product development.